Renal Insufficiency Market Report 2025-2034: Industry Overview, Trends, And Forecast Analysis

"We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.

What Is the Current Renal Insufficiency Market Size and Its Estimated Growth Rate?
The market size of renal insufficiency has seen a significant expansion in the past few years. The estimations project growth from $10.87 billion in 2024 to as much as $12.14 billion in 2025, marking a compound annual growth rate (CAGR) of 11.7%. The historic growth spree can be tied to a rise in the instances of hypertension and diabetes, increased diagnosis of chronic kidney disease (CKD), more incidences of obstructions encountered in the urinary tract, an overall aging population, and the escalating level of awareness and education related to kidney health.

Rapid expansion is anticipated for the renal insufficiency market in the upcoming years, with projections setting it at $18.68 billion by 2029, increasing at a compound annual growth rate (CAGR) of 11.4%. This growth during the forecasted period can be linked to factors such as the rising incidence of acute kidney injuries (AKI), the increasing preference for home-based treatment methods, a surge in healthcare spending, and investment in research and development. Significant trends anticipated during this time frame include medical technology advancements, technological progress in treatment options, the incorporation of personalized medicine, advancement in dialysis technology, and the creation of novel and innovative medicines.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=21271

How Are Emerging Segments Shaping the Renal Insufficiency Market Landscape?
The renal insufficiency market covered in this report is segmented -

1) By Treatment Type: Medications, Dialysis, Kidney Transplantation, Other Treatment Types
2) By Disease Stage: Chronic Kidney Disease (CKD) Stages, End-Stage Renal Disease (ESRD)
3) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies
4) By End-User: Dialysis Centers, Hospital And Clinics, Research And Academic Institutes

Subsegments:
1) By Medications: Angiotensin-Converting Enzyme (ACE) Inhibitors, Angiotensin II Receptor Blockers (ARBs), Diuretics, Erythropoiesis-Stimulating Agents (ESAs), Phosphate Binders, Sodium Bicarbonate
2) By Dialysis: Hemodialysis, Peritoneal Dialysis, Home Dialysis, Continuous Renal Replacement Therapy (CRRT)
3) By Kidney Transplantation: Living Donor Kidney Transplant, Deceased Donor Kidney Transplant, Kidney Transplant Immunosuppressive Therapy
4) By Other Treatment Types: Lifestyle And Dietary Modifications, Stem Cell Therapy, Gene Therapy

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=21271&type=smp

Which Growth Factors Are Influencing Renal Insufficiency Market Expansion?
The rise in cases of hypertension and diabetes is presumed to fuel the expansion of the renal insufficiency market. These health issues, both hypertension and diabetes, stem from factors such as unhealthy diet, lack of regular exercise, obesity, inherent genetic traits, and the increasing age factor. Hypertension leads to the damage of kidney blood vessels by leading to scarring and reduced filtration. Diabetes, on the other hand, puts stress on the kidney vessels due to elevated blood sugar levels; this intensifying kidney affliction and culminating in renal insufficiency. Notably, in May 2024, the National Health Service, a government agency based in the UK, reported that the South East saw an increase of 71,120 hypertension diagnoses in December 2023-5.4% more than in December 2022. Furthermore, in April 2023, the British Diabetic Association, a charitable organization based in the UK, stated that about 4.3 million people in the UK are diagnosed with diabetes. It is this rising prevalence of hypertension and diabetes that is propelling the growth of the renal insufficiency market.

Who Are the Dominant Players Across Different Renal Insufficiency Market Segments?
Major companies operating in the renal insufficiency market are Kaiser Permanente, Johnson & Johnson, Roche Holding AG, Sanofi S.A., Abbott Laboratories, Medtronic plc, Amgen Inc., Asahi Kasei Medical Co. Ltd., Fujifilm Holdings Corporation, Fresenius Medical Care, Toray Industries Inc., Baxter International Inc., Boehringer Ingelheim, DaVita Inc., Eisai Co. Ltd., Nipro Corporation, Biocon Limited, HemoCue AB, Rockwell Medical, Mitsubishi Tanabe Pharma Corporation, Sorin Group.

What Are the Latest Developing Trends in the Renal Insufficiency Market?
Key players in the renal insufficiency market are progressing with the development of glucagon-like peptide-1 receptor agonists (GLP-1 RAs). These are designed to combat the renal and heart complications commonly seen in patients struggling with diabetes and chronic kidney disease (CKD). GLP-1 RAs are effective in regulating glucose levels, lowering inflammation, and reducing oxidative stress in the kidneys, thereby decelerating the advancement of renal insufficiency. For instance, in January 2025, an approval from the Food and Drug Administration (FDA) was granted to Novo Nordisk, a pharmaceutical company from Denmark, for their product Ozempic (semaglutide). This drug is intended to lessen the risks associated with deteriorating kidney disease, kidney failure, and death from cardiovascular issues in adults that suffer from type 2 diabetes and chronic kidney disease (CKD). The approval accentuates the increasing focus on GLP-1 RAs as a dual treatment option for both diabetes and renal insufficiency, addressing important unfulfilled needs of patients with advancing CKD.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/renal-insufficiency-global-market-report

Which Geographic Regions Are Expected to Dominate the Renal Insufficiency Market in the Coming Years?
North America was the largest region in the renal insufficiency market in 2024. The regions covered in the renal insufficiency market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Renal Insufficiency Market?
2. What is the CAGR expected in the Renal Insufficiency Market?
3. What Are the Key Innovations Transforming the Renal Insufficiency Industry?
4. Which Region Is Leading the Renal Insufficiency Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments."

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.